You are viewing: Rest Of Europe Mental Health Screening Market analysis
Part of: Mental Health Screening Market (Global)

The Rest Of Europe Mental Health Screening Market was valued at $80.7 Million in 2023 and projected to reach to $151.4 Million by 2028, representing a compound annual growth rate of 11.1%. Rest Of Europe's mental health screening market is positioned for sustained expansion through 2028, driven by heightened awareness of mental health disorders and supportive regulatory environments across the region.

Rest Of Europe Mental Health Screening Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Europe Mental Health Screening Market Trends and Insights

  • Rest Of Europe's market expansion reflects increasing awareness of mental health disorders, rising healthcare expenditure, and growing adoption of digital screening tools across the region.
  • The 11.1% compound annual growth rate demonstrates Rest Of Europe's commitment to integrating mental health screening into primary care and workplace wellness programs. Rest Of Europe is witnessing accelerated demand driven by regulatory initiatives, healthcare digitalization, and workforce mental health priorities.
  • Between 2023 and 2028, Rest Of Europe's market is expected to nearly double, supported by improved access to screening technologies and enhanced reimbursement policies.
  • Rest Of Europe's diverse healthcare systems are increasingly recognizing mental health screening as essential infrastructure for early intervention and population health management..

Key Market Statistics

  • CAGR (2023-2028) 11.1% CAGR
  • Market Size, 2023 ~USD 80.7 Million
  • Forecast, 2028 ~USD 151.4 Million
  • Country Rest Of Europe

Rest Of Europe Mental Health Screening Market Overview

Market Valuation Growth :

Rest Of Europe's mental health screening market reached $80.7 million in 2023 and is projected to grow to $151.4 million by 2028, representing an 87.4% increase over the five-year forecast period.

Regional CAGR Performance :

The region demonstrates a solid 11.1% compound annual growth rate, driven by increased mental health awareness campaigns and policy initiatives across European nations outside major markets.

Digital Screening Adoption :

Rest Of Europe is witnessing accelerated adoption of digital mental health screening tools, reflecting the region's modernization of healthcare infrastructure and telehealth integration across smaller European markets.

Healthcare Investment Trends :

Rising healthcare expenditure across Rest Of Europe countries is fueling investment in mental health screening programs, supported by government initiatives and increased private sector participation in mental wellness services.

Rest Of Europe Mental Health Screening Market Dynamics

  • Healthcare providers are increasingly prioritizing early detection and preventive screening, supported by growing digital health infrastructure and cross-border healthcare collaboration initiatives. The region's market growth is further accelerated by rising healthcare budgets, workforce development in mental health services, and integration of AI-powered screening solutions.
  • Emerging European markets are adopting standardized mental health assessment protocols, creating opportunities for both established and innovative screening solution providers to capture market share in this underserved but rapidly developing segment..

Related Ecosystem

Healthcare It

Top Technologies
  • Computed Tomography (CT)
  • Machine Learning
  • Magnetic Resonance Imaging (MRI)
  • Natural Language Processing (NLP)
  • Predictive Analytics
Top Companies
  • CERNER CORPORATION
  • PHILIPS HEALTHCARE
  • Oracle Corporation
  • GE HealthCare Technologies Inc.
  • Siemens healthineers

    Key Takeaways

    • Rest Of Europe's mental health screening market is valued at $80.7 million in 2023 and will reach $151.4 million by 2028, representing an 11.1% CAGR.
    • Rest Of Europe is experiencing accelerated digital health adoption, with screening platforms increasingly integrated into primary care and occupational health services.
    • Rest Of Europe's market growth is driven by regulatory mandates, improved mental health awareness, and workplace wellness initiatives across multiple countries.
    • Rest Of Europe's healthcare systems are investing in scalable screening infrastructure to address rising mental health prevalence and support early intervention strategies.

    Mental Health Screening Market Report Scope

    Report Metric Details
    Base Year 2023
    Fastest Growing Segment COGNITIVE (Application)
    Forecast Period 2023-2028
    Growth Rate CAGR of 12.2% from 2023 to 2028
    Largest Segment ADULTS (AGE 19-64 YEARS) (Age Group)
    Market Size Base Year (Billions) ~USD 0.9 (2023)
    Revenue Forecast (Billions) ~USD 1.6 (2028)
    Segments Covered Application, Type, Screening Method, Technology, Age Group, Setting

    Rest Of Europe Mental Health Screening Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Application

    • Behavioral Disorders
    • Cognitive
    • Cognitive Disorders
    • Physiological Disorders
    • Psychiatric Disorders

    By Type

    • Aggression
    • Alzheimer'S Disease
    • Anxiety
    • Attention Deficit Hyperactivity Disorder (Adhd)
    • Beck Depression Inventory (Bdi)
    • Bipolar Disorder
    • Cognitive Impairment
    • Dementia
    • Depression
    • Diagnostic Interview For Psychological Distress (Dipd)
    • Dissociative Disorder
    • Eating Disorder
    • Generalized Anxiety Disorder-7 (Gad-7)
    • Hamilton Anxiety Rating Scale (Ham-A)
    • Hyperactivity
    • Mini International Neuropsychiatric Interview (Mini)
    • Obsessive Compulsive Disorder (Ocd)
    • Other Behavioral Disorders
    • Other Clinical Interviews
    • Other Cognitive Disorders
    • Other Physiological Disorders
    • Other Psychiatric Disorders
    • Other Self-Reported Questionnaires & Surveys
    • Patient Health Questionnaire-12 (Phq-12)
    • Post-Traumatic Stress Disorder (Ptsd)
    • Post-Traumatic Stress Disorder (Ptsd)
    • Psychotic Disorder
    • Schizophrenia
    • Self-Harm
    • Sleep Disorders
    • Social Withdrawal
    • Structured Clinical Interview For Dsm (Scid)
    • Structured Clinical Interviews For Dsm (Scid)
    • Substance Abuse
    • Yale-Brown Obsessive Compulsive Scale (Y-Bocs)

    By Screening Method

    • Biomarker Testing
    • Clinical Interviews
    • Observation-Based Assessments
    • Self-Reported Questionnaires & Surveys

    By Technology

    • AI-Based Screening Tools
    • Continuous Monitoring Wearable Devices
    • Remote Mental Health Platforms
    • Self-Screening Mhealth Apps
    • Telehealth & Virtual Care Solutions

    By Age Group

    • Adults (Age 19-64 Years)
    • Children & Adolescents (0-18 Years)
    • Children & Adolescents (Age 0-18 Years)
    • Seniors (Age 65 And Above)

    By Setting

    • Clinical Settings
    • Educational Institutions
    • Online Platforms
    • Other Settings
    • Workplace/Corporate Programs

    Target Audience

    • Healthcare Providers & Hospitals : Rest Of Europe healthcare facilities need market data to evaluate mental health screening technology investments, benchmark against regional peers, and plan service expansion aligned with growing demand across their markets.
    • Mental Health Technology Vendors : Software and diagnostic solution providers targeting Rest Of Europe require regional market insights to identify growth opportunities, understand adoption barriers, and develop localized go-to-market strategies for screening platforms.
    • Healthcare Investors & PE Firms : Investment professionals evaluating opportunities in Rest Of Europe's mental health sector need comprehensive market data, growth projections, and competitive analysis to assess portfolio companies and identify acquisition targets.
    • Government & Policy Makers : Healthcare administrators and policymakers across Rest Of Europe use market research to inform mental health funding decisions, regulatory frameworks, and public health initiatives aligned with regional screening market trends.
    • Pharmaceutical & Diagnostic Companies : Pharma and diagnostic firms expanding into Rest Of Europe mental health markets require regional market sizing, treatment pathway data, and screening adoption rates to support product launches and clinical trial planning.

    Reasons to Buy this Report

    • Regional Market Sizing & Forecasts : Obtain precise valuation data specific to Rest Of Europe ($80.7M in 2023, $151.4M by 2028) with detailed year-over-year projections to support strategic planning and investment decisions in this emerging regional market.
    • Competitive Landscape Analysis : Understand market dynamics, key players, and competitive positioning within Rest Of Europe's mental health screening sector to identify partnership opportunities and market entry strategies tailored to regional conditions.
    • Growth Driver Identification : Gain insights into region-specific factors driving the 11.1% CAGR, including digital tool adoption rates, healthcare expenditure trends, and regulatory developments unique to Rest Of Europe markets.
    • Customer Segmentation Data : Access detailed breakdowns of end-user segments across Rest Of Europe including hospitals, clinics, private practices, and telehealth providers to tailor product offerings and marketing strategies effectively.
    • Investment & Expansion Strategy : Leverage comprehensive Rest Of Europe market intelligence to evaluate expansion feasibility, identify high-growth sub-regions, and develop data-backed business cases for market entry or portfolio expansion decisions.

    Frequently asked questions

    What is the current market size of mental health screening in Rest Of Europe?

    Rest Of Europe's mental health screening market was valued at $80.7 million in 2023 and is projected to grow to $151.4 million by 2028.

    What is the expected growth rate for Rest Of Europe's mental health screening market?

    Rest Of Europe's mental health screening market is expected to grow at a compound annual growth rate (CAGR) of 11.1% from 2023 to 2028.

    What factors are driving growth in Rest Of Europe's mental health screening market?

    Rest Of Europe's market growth is driven by increased mental health awareness, regulatory initiatives, digital health adoption, workplace wellness programs, and improved healthcare reimbursement policies.

    How is digital technology impacting Rest Of Europe's mental health screening market?

    Rest Of Europe is experiencing rapid adoption of digital screening tools, telemedicine platforms, and AI-enabled assessment solutions that improve accessibility and efficiency in mental health screening.

    Which sectors are investing most in mental health screening in Rest Of Europe?

    Rest Of Europe's primary care providers, occupational health services, insurance companies, and government health systems are leading investments in mental health screening infrastructure.

    RESEARCH METHODOLOGY

    This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the Mental Health Screening market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Some non-exclusive secondary sources include the World Health Organization (WHO), the Organisation for Economic Co-operation and Development (OECD), Agency for Healthcare Research and Quality (AHRQ), Primary Care Companion for CNS Disorders Journal, Centers for Medicare & Medicaid Services (CMS), Centers for Disease Control and Prevention (CDC), Expert Interviews, and MarketsandMarkets Analysis.

    Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital personnel, department heads, hospital directors, corporate personnel) and supply side (such as C-level and D-level executives, technology experts, software developers, marketing and sales managers, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    Breakdown of Primary Interviews

    Health Screening Market Size, and Share

    Note 1: Tiers are defined based on the total revenues of companies. As of 2022, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the mental health screening market was arrived at after data triangulation from various approaches, as mentioned below. After completing each approach, a weighted average of the three approaches was taken based on the level of assumptions used in each approach.

    Approach 1: Mental Health Screening Market (Revenue Share Analysis)

    • Revenues for individual companies were gathered from public sources and databases for each market segment.
    • Revenues of private companies were gathered through paid databases such as Factiva and Hoovers.
    • Shares of the mental health screening businesses of leading players were gathered from secondary sources to the extent available. In certain cases, shares have been ascertained after a detailed analysis of various parameters, including product portfolios, market positioning, and geographic reach.
    • Individual shares or revenue estimates were validated through expert interviews.
    • The market size was then extrapolated to obtain the global market. It was further validated through expert interviews.

    Approach 2: Segmental Extrapolation

    Separate research approaches were followed to estimate the revenue from mental health screening tools and continuous monitoring wearable devices used for mental health screening.

    • Mental health screening tools (excluding continuous monitoring wearable devices):
    • The total number of psychiatrists in the US was determined for 2022. The percentage of psychiatrists using mental health screening tools offered by vendors was identified through extensive secondary research and validated through insights from primary interviews.
    • The average price of mental health screening tools for yearly subscriptions was considered to arrive at the US mental health screening market for clinical settings in 2022.
    • Considering the share of clinical settings, revenues of the overall market in the US were determined for 2022.
    • The US mental health screening market was extrapolated to arrive at the global market.
    • The market for continuous monitoring wearable devices:
    • The total prevalence of mental health disorders in the US was determined for 2022, and the share of people opting for assessments was identified through extensive secondary research and validated through insights from primary interviews.
    • The share of people using continuous monitoring wearable devices for mental health screening was assumed based on secondary research and insights from primary interviews.
    • The average price of continuous monitoring wearable devices was determined through secondary sources to arrive at the US market for continuous monitoring wearable devices.
    • The US market for continuous monitoring wearable devices was extrapolated to arrive at the global market for continuous monitoring wearable devices.
    • The sum of revenues from mental health screening tools and continuous monitoring wearable devices used for mental health screening provided the revenue of the global mental health screening market. The assumptions at each step were validated through primary interviews.

    Approach 3: Primary Interviews

    • As a part of the primary research process, individual respondents’ insights on the market size and growth were taken during the interview (regional and global, as applicable).
    • All the responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.

    Data Triangulation:

    After arriving at the overall market size, from the market size estimation process explained above, the Mental Health Screening market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Mental Health Screening market.

    Market Definition:

    Mental health screening refers to the process of assessing an individual’s mental health status to identify potential signs or symptoms of mental health conditions. It is a preliminary step in recognizing and addressing mental health concerns early on. The goal of mental health screening is to identify individuals who may be at risk of or experiencing mental health issues so that appropriate interventions, support, or further assessments can be provided.

    Screening tools may include questionnaires, surveys, or interviews that assess various aspects of an individual’s mental health, such as mood, behavior, thoughts, and emotions. These screenings are often administered by healthcare professionals, counselors, or mental health providers in different settings, including schools, workplaces, clinical settings, and others.

    Key Stakeholders:

    • Manufacturers of mental health screening solutions/products
    • Suppliers and distributors of mental health screening solutions/products
    • Third-party refurbishers/suppliers
    • Clinical settings
    • Educational institutions
    • Group purchasing organizations (GPOs)
    • Academic medical centers and universities
    • Corporate entities
    • Community centers
    • Government institutes
    • Market research & consulting firms
    • Contract manufacturing organizations (CMOs)
    • Venture capitalists & investors

    Report Objectives

    • To define, describe, and forecast the mental health screening market by application, screening method, technology, age group, setting, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall mental health screening market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To profile the key players in the market and comprehensively analyze their market shares and core competencies
    • To forecast the size of the market segments with respect to five main regions: North America, the Asia Pacific, Europe, Latin America, and the Middle East & Africa
    • To track and analyze competitive developments, such as partnerships, acquisitions, and launches
    • To benchmark players within the mental health screening market using the Competitive Evaluation Matrix, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

    Available Customizations:

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Additional Company Profiling

    • Detailed analysis and profiling of additional market players (up to 5)

    Geographic Analysis

    • Further breakdown of the Rest of Europe mental health screening market into Spain, Italy, Russia, and others
    • Further breakdown of the Rest of Asia Pacific mental health screening market into Australia, South Korea, Singapore, and others

    Get the Full Mental Health Screening Market Report

    Full forecast, segment splits, and company analysis for all Mental Health Screening Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status